BioSpace News Archive

BioMidwest

Samaritan Pharmaceuticals, Inc. Highlights Its Most Innovative HIV, Hepatitis C and Alzheimer’s Drugs to Partner at Europe’s Bio Partnering Conference

October 8, 2007
·
1 min read
Genetown

Momenta Pharmaceuticals, Inc. to Present at the Biotechnology Industry Organization (BIO) Investor Forum

October 8, 2007
·
1 min read
Drug Development

MediciNova, Inc. Will Announce Clinical Results From a Phase IIa Clinical Study for MN-221, a Novel Treatment for Status Asthmaticus, On Tuesday, October 9, 2007 At 3:00 a.m. Eastern Time

October 8, 2007
·
1 min read
Biotech Beach

Optimer Pharmaceuticals, Inc.: Leading Medical Experts Call for More Effective Strategies to Address Clostridium difficile-Associated Disease

October 8, 2007
·
1 min read
Drug Development

Alnylam Pharmaceuticals Presents First Ever Non-Human Primate Data with an RNAi Therapeutic Targeting PCSK9 Showing Significant and Durable Reductions in LDL Cholesterol Levels

October 8, 2007
·
1 min read
Drug Development

Akesis Pharmaceuticals Files IND for Phase IIa Trial of AKP-020 to Treat Type 2 Diabetes

October 8, 2007
·
1 min read
Business

SCOLR Pharma, Inc. Announces the Addition of Jeff Reich, M.D. and Greg Weaver to its Board of Directors

October 8, 2007
·
1 min read
Business

Biophan Technologies, Inc. Announces Resignation of President

October 8, 2007
·
1 min read
Policy

Accentia, Inc. Announces Investigational New Drug Application for Revimmune Usage in a Pivotal Phase 3 Study of Refractory Multiple Sclerosis

October 8, 2007
·
1 min read
Drug Development

Xanthus Pharmaceuticals, Inc. Initiates Pivotal Phase 3 Trial of Xanafide in Secondary Acute Myeloid Leukemia

October 8, 2007
·
1 min read